← Back to Patent Explorer
US5543397A Expired / Lapsed US ⏱️ 0.0 years remaining

New N-acyl dipeptides and their use

Assignee: Evonik Operations GmbH
•
Filing: 1994-06-07
•
Granted: 1996-08-06
•
Expires: 2014-06-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel N-acyl depeptides of the formula: R.sup.2 --NH--CHR.sup.1 --CO--AS in which AS, R 1 and R 2 have certain, more precisely defined meanings. These N-acyl dipeptides are more stable under conditions of sterilization (121° C.) than corresponding, non-acylated dipeptides. On the other hand, they are cleaved more rapidly and more completely at the peptide bond in the living organism than the cleavage of the acyl group from simple N-acyl amino acids takes place. They can therefore be used with advantage as a source for the carbon terminal amino acid in mixtures and solutions for artificial nutrition or in culture media for cell cultures.

Inventors

  • 👤 Karlheinz Drauz
  • 👤 G unter Knaup
  • 👤 Ulrich Groeger

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 19:47
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/06; C07K5/06008; C07K5/06017; C07K5/06034; C07K5/06043; A; A23; A23L; A23L33/00; A23L33/10; A23L33/17; C07K5/06026; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 108 words
A composition suitable for use as a glutamine source in a culture medium, comprising an N-acyl dipeptide of the formula: R.sup.2 --NH--CHR.sup.1 --CO--AS (I') in which AS stands for the residue obtained by removing a hydrogen from the nitrogen atom of an amino acid selected from the group consisting of valine, leucine, isoleucine, tryosine, tryptophan, glutamine and cysteine, when R 1 signifies the side chain of a natural amino acid and R 2 a formyl- or acetyl group or an acyl group of an aliphatic mono- or dicarboxylic acid containing 3 to 6 carbon atoms, and their physiologically compatible carboxylic-acid salts as a source for said amino acid.
Claim 2
Dependent Claim 108 words
A composition suitable for use as a glutamine source in a culture medium, comprising an N-acyl dipeptide of the formula: R.sup.2 --NH--CHR.sup.1 --CO--AS (I') in which AS stands for the residue obtained by removing a hydrogen from the nitrogen atom of an amino acid selected from the group consisting of valine, leucine, isoleucine, tryosine, tryptophan, glutamine and cysteine, when R 1 signifies the side chain of a natural amino acid and R 2 a formyl- or acetyl group or an acyl group of an aliphatic mono- or dicarboxylic acid containing 3 to 6 carbon atoms, and their physiologically compatible carboxylic-acid salts as a source for said amino acid.
Claim 3
Dependent Claim 16 words
A culture medium as set forth in claim 1 in which the N-acyl dipeptide is N-acetyl-L-alanyl-L-glutamine.
Claim 4
Dependent Claim 16 words
The composition according to claim 1, wherein said culture medium is a tissue cell culture medium.

References Cited (Backward Citations)

GB2071670A Cited
EP0050196A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-08-06 2000-02-05 2000-08-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-08-06 2004-02-05 2004-08-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-08-06 2008-02-05 2008-08-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag